Introduction: Shandong Runhua Pharmaceutical Co., Ltd. is a traditional Chinese medicine pharmaceutical enterprise controlled by Runhua Group Co., Ltd. and integrates scientific research, production and sales. The company has strong strength and assets of over 100 million. It is a high-tech enterprise in Shandong Province with the national "863 Plan" project.
The company is located in Zhangqiu Mingshui Economic Development Zone, Jinan City. It has five production lines for tablets, mixtures, capsules, granules, and oral liquids (including a traditional Chinese medicine extraction workshop), all of which have passed GMP certification. At present, the company has an annual production capacity of extracting 2,200 tons of traditional Chinese medicine extracts, producing 1.5 billion tablets, 1 million bottles of mixtures, 300 million capsules, 50 million bags of granules, and 10 million oral liquids.
The "Tuberculosis Tablets" developed by the company in collaboration with Shandong University of Traditional Chinese Medicine and Shandong Provincial Hospital of Traditional Chinese Medicine were successfully approved by the national "863" program in April 2004 and successfully passed the acceptance of the National Ministry of Science and Technology. The company has been awarded honors and titles such as High-tech Enterprise, Traditional Chinese Medicine Modernization Demonstration Enterprise, Jinan Enterprise Technology Center, and Jinan Key Leading Enterprise by relevant government agencies. In 2009, the "Runhua" trademark used by the company was rated as a "Famous Trademark of Shandong Province", and in 2010, it was rated as an enterprise that "observes contracts and values ??credit".
As a well-known brand in Shandong, Shandong Runhua Pharmaceutical Co., Ltd.’s products have been recognized by customers for their reliable quality and significant efficacy, and are sold well in more than a dozen provinces including Shandong, Jiangsu, Liaoning, and Hebei. Among them, two varieties, Jinling Cold Tablets and Pediatric Shuangjin Qingre Oral Liquid, are exclusive products. Jinling Cold Tablets are a national protected variety of traditional Chinese medicine, and Pediatric Shuangjin Qingre Oral Liquid is refined from 16 pure Chinese medicine preparations. It has won praise from consumers for its safety and significant efficacy. Hugan Granules and Compound Berberine have been included in the "National Essential Medicines List"; Andrographis Paniculata Tablets, Hugan Granules, Compound Berberine Tablets, and Xinkening Capsules have been included in the "National Medical Insurance Catalog"; Jinling Cold Tablets, Chuanshu Tablets, and Hugan Tablets Liver tablets, compound Daqing leaves and Andrographis paniculata tablets have been included in the "Basic Drug List for Rural Doctors in Shandong Province".
At present, the company has nearly 300 employees, 35 of whom have a bachelor's degree or above. It has a stable management team and professional scientific research force.
Shandong Runhua Pharmaceutical Co., Ltd. takes "revitalizing Chinese medicine, benefiting mankind, being honest and trustworthy, and benefiting people" as its purpose. It is based on the pharmaceutical industry and timely gets involved in the health industry; based on the Shandong market, it builds the national market. Aiming to develop into a professional pharmaceutical enterprise with high profitability and influence in the pharmaceutical industry. And after a certain amount of accumulation, it will enter the capital market as soon as possible.
Legal representative: Sun Guangrui
Date of establishment: 1994-05-20
Registered capital: RMB 55 million
Region : Shandong Province
Unified Social Credit Code: 91370181613207100A
Business status: Operating (opening) enterprise
Industry: Manufacturing
Company type: Limited liability company (a sole proprietorship of a legal person invested or controlled by a natural person)
Staff size: 100-499 people
Company address: Mingshui Economic, Zhangqiu City, Jinan City, Shandong Province Industrial 1st Road, Development Zone
Business scope: production and self-sale: oral liquid, tablets, mixtures, powders, hard capsules, granules, raw materials (montmorillonite) (validity period is based on the license) quasi); biotechnology research and development. (Projects that require approval according to law can only be carried out with approval from relevant departments)